C185942Level 4
Afatinib/Cetuximab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of afatinib and cetuximab that may be used in the treatment of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).
**Synonyms:** - Afatinib Plus Cetuximab - Afatinib and Cetuximab - Afatinib-Cetuximab - Afatinib-Cetuximab Regimen - Afatinib/Cetuximab - Cetuximab-Afatinib - Cetuximab/Afatinib - Cetuximab/Afatinib Regimen - Gilotrif/Erbitux
GET
/api/v1/systems/nci_thesaurus/nodes/C185942Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.